CinCor Pharma

0 followers


CinCor is a clinical-stage cardiorenal therapeutics company with a novel clinical-stage candidate, CIN-107 that has the potential to dramatically expand therapeutic options for patients suffering from hypertension and its associated risks.

Industries

Employees

11-50

Links


Org chart

Collapse
Kevin Schutz, PharmD
Vice President Regulatory Affairs
Mason W. Freeman
EVP, Clinical Operations

Board & advisors

Suzanne Oparil
Scientific Advisor
Ulrich Granzer
Scientific Advisor
Morris Brown
Scientific Advisor
Philip T. Sager
Scientific Advisor
Bryan Williams
Scientific Advisor
John Kastelein
Scientific Advisor
Patrick Rossignol
Scientific Advisor